Genfit SA GNFT-FR:Euronext Paris

*Data is delayed | EUR
Last | 04/13/21 CEST
3.92UNCH (UNCH)
52 week range
3.02 - 20.96

...

Loading . . .
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.92
  • 52 Week High20.96
  • 52 Week High Date04/21/20
  • 52 Week Low3.02
  • 52 Week Low Date10/28/20

Key Stats

  • Market Cap183.31M
  • Shares Out38.86M
  • 10 Day Average Volume188,716.9
  • Dividend-
  • Dividend Yield-
  • Beta1.05
  • YTD % Change-1.8

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.92
  • 52 Week High20.96
  • 52 Week High Date04/21/20
  • 52 Week Low3.02
  • 52 Week Low Date10/28/20
  • Market Cap183.31M
  • Shares Out38.86M
  • 10 Day Average Volume188,716.9
  • Dividend-
  • Dividend Yield-
  • Beta1.05
  • YTD % Change-1.8

RATIOS/PROFITABILITY

  • EPS (TTM)-2.61
  • P/E (TTM)-1.50
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From Genfit SA

There is no recent news for this security.

Latest From Our Partners

Profile

MORE
Genfit SA is a France-based biopharmaceutical company that specializes in the development of medicines for the prevention and treatment of diabetes and related disorders. The Company is focused on contributing to bringing medicines to market for patients with metabolic, inflammatory, autoimmune and fibrotic diseases that affect the liver, such as Nonalcoholic steatohepatitis (NASH) or the bowel, such as the inflammatory bowel disease. The Company targets a number of...
Jean-Francois Mouney
Chairman
Xavier Guille Des Buttes
Non-Executive Chairman
Pascal Prigent
Chief Executive Officer
Dean Hum Ph.D.
Chief Operating Officer
Nathalie Huitorel
Chief Financial Officer
Address
Parc Eurasante 885 avenue Eugene Avinee
Loos
59120
France